A bipartisan bill brought forward in the U.S. House of Representatives April 4 would coordinate an international initiative for the prevention and treatment of Alzheimer’s disease and other dementias.

GE Healthcare announced yesterday that the U.S. Food and Drug Administration (FDA) has provided 510(k) clearance for the company’s PET/CT iterative image reconstruction technology that works to improve image quality and quantitative data.

The continuation of clinical trials for Alzheimer’s disease is dependent upon identification of their challenges as well as strategies for improvement, according to a review published in the April issue of Health Affairs. 

MRI could be of value in the diagnosis of prostate cancer in patients with histories of negative biopsies and elevated levels of prostate-specific antigen (PSA), according to a study published in the May issue of Academic Radiology. 

Shine Medical Technologies based in Monona, Wis., has solidified a deal with GE Healthcare to provide consistent production of molybdenum-99, which decays into technetium-99m—the medical isotope most used throughout the world in nuclear medicine procedures, the company announced last week.

Drug policy in the European Union could change in the not too distant future depending on a vote regarding a law proposed to discourage pharmaceutical companies from playing favorites when it comes to clinical trials.

While the prostate naturally relies on lipid metabolism, there is a way to reroute metabolic function and activate glucose uptake, which provides a novel means of FDG and other metabolic prostate imaging, according to a study presented during the American Association for Cancer Research (AACR) annual meeting being held April 5-9 in San Diego, Calif.

The recent report from the Canadian National Breast Screening Study (CNBSS) that concluded that mammography screening does not reduce deaths from breast cancer has sparked new thought on how to frame issues associated with breast cancer screening, as evidenced by two commentaries published on April 8 in Annals of Internal Medicine.